Axel F. Sigurðsson

Icelandic Heart Association ·

Area of research

Cardiology and Cardiovascular Medicine · Surgery

Research interest

Research interests include Heart Failure Treatment and Management, Cardiac electrophysiology and arrhythmias, Atrial Fibrillation Management and Outcomes, and Coronary Interventions and Diagnostics.

h-index

citations

3,436

works

NIH funding

—

primary concept

Medicine

✉ Find email ↗

Recent publications

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

The Lancet 2017cited by 1,300position: middledoi

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

The Lancet 2017cited by 869position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

No co-authors indexed yet.